These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35334088)

  • 1. Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process.
    Ha S; Chung KW; Lee J; Chung HY; Moon HR
    Arch Pharm Res; 2022 Mar; 45(3):159-173. PubMed ID: 35334088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PAR2 promotes high-fat diet-induced renal injury by inducing oxidative stress and inflammation.
    Ha S; Yang Y; Kim BM; Kim J; Son M; Kim D; Yu HS; Im DS; Chung HY; Chung KW
    Biochim Biophys Acta Mol Basis Dis; 2022 Oct; 1868(10):166474. PubMed ID: 35772632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidney.
    Ma FY; Han Y; Ozols E; Chew P; Vesey DA; Gobe GC; Morais C; Lohman RJ; Suen JY; Johnson DW; Fairlie DP; Nikolic-Paterson DJ
    Nephrology (Carlton); 2019 Sep; 24(9):983-991. PubMed ID: 31314137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAR2-mediated cellular senescence promotes inflammation and fibrosis in aging and chronic kidney disease.
    Ha S; Kim HW; Kim KM; Kim BM; Kim J; Son M; Kim D; Kim MJ; Yoo J; Yu HS; Jung YS; Lee J; Chung HY; Chung KW
    Aging Cell; 2024 Aug; 23(8):e14184. PubMed ID: 38687090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-β receptor signaling pathways contributes to renal fibrosis.
    Chung H; Ramachandran R; Hollenberg MD; Muruve DA
    J Biol Chem; 2013 Dec; 288(52):37319-31. PubMed ID: 24253040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptor 2 exacerbates adenine-induced renal tubulointerstitial injury in mice.
    Hayashi S; Oe Y; Fushima T; Sato E; Sato H; Ito S; Takahashi N
    Biochem Biophys Res Commun; 2017 Jan; 483(1):547-552. PubMed ID: 28025140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR7 activation by miR-21 promotes renal fibrosis by activating the pro-inflammatory signaling pathway in tubule epithelial cells.
    Kim J; Ha S; Son M; Kim D; Kim MJ; Kim B; Kim D; Chung HY; Chung KW
    Cell Commun Signal; 2023 Aug; 21(1):215. PubMed ID: 37596656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease.
    Mitsui S; Oe Y; Sekimoto A; Sato E; Hashizume Y; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1067-F1073. PubMed ID: 32200667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salidroside Ameliorates Renal Interstitial Fibrosis by Inhibiting the TLR4/NF-κB and MAPK Signaling Pathways.
    Li R; Guo Y; Zhang Y; Zhang X; Zhu L; Yan T
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30836660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease-Activated Receptor-2 and Phospholipid Metabolism Analysis in Hyperuricemia-Induced Renal Injury.
    Sui X; Xie T; Xu Y; Zhang A; Zhang Y; Gu F; Li L; Xu Z; Chen J
    Mediators Inflamm; 2023; 2023():5007488. PubMed ID: 37484603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptor 2 exacerbates cisplatin-induced nephrotoxicity.
    Watanabe M; Oe Y; Sato E; Sekimoto A; Sato H; Ito S; Takahashi N
    Am J Physiol Renal Physiol; 2019 Apr; 316(4):F654-F659. PubMed ID: 30672316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease-activated receptor 2 induces migration and promotes Slug-mediated epithelial-mesenchymal transition in lung adenocarcinoma cells.
    Tsai CC; Chou YT; Fu HW
    Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):486-503. PubMed ID: 30321617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nupr1 mediates renal fibrosis via activating fibroblast and promoting epithelial-mesenchymal transition.
    Zhou R; Liao J; Cai D; Tian Q; Huang E; Lü T; Chen SY; Xie WB
    FASEB J; 2021 Mar; 35(3):e21381. PubMed ID: 33617091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished Tubule Epithelial Farnesoid X Receptor Expression Exacerbates Inflammation and Fibrosis Response in Aged Rat Kidney.
    Ha S; Yang Y; Won Kim J; Son M; Kim D; Kim MJ; Im DS; Young Chung H; Chung KW
    J Gerontol A Biol Sci Med Sci; 2023 Jan; 78(1):60-68. PubMed ID: 35867996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro.
    Liu B; Ding F; Hu D; Zhou Y; Long C; Shen L; Zhang Y; Zhang D; Wei G
    Stem Cell Res Ther; 2018 Jan; 9(1):7. PubMed ID: 29329595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of protease-activated receptor 2 ameliorated osteoarthritis in rats through regulation of MAPK/NF-κB signaling pathway in vivo and in vitro.
    Yan S; Ding H; Peng J; Wang X; Pang C; Wei J; Wei J; Chen H
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32134473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease-activated receptor 2 deficiency in hematopoietic lineage protects against myocardial infarction through attenuated inflammatory response and fibrosis.
    Zuo P; Zhu Y; Li Y; Zuo Z; Sheng Z; Yan G; Ma G
    Biochem Biophys Res Commun; 2020 May; 526(1):253-260. PubMed ID: 32204916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonic hedgehog-mediated epithelial-mesenchymal transition in renal tubulointerstitial fibrosis.
    Bai Y; Lu H; Lin C; Xu Y; Hu D; Liang Y; Hong W; Chen B
    Int J Mol Med; 2016 May; 37(5):1317-27. PubMed ID: 27035418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
    Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
    Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.